CollPlant Biotechnologies (CLGN) Asset Utilization Ratio (2018 - 2025)
CollPlant Biotechnologies (CLGN) reported Asset Utilization Ratio of 0.19 for Q4 2025, up 246.72% on a YoY basis from 0.05 in Q4 2024, and up 21.42% quarter-over-quarter from 0.16 in Q3 2025.
CollPlant Biotechnologies (CLGN) Asset Utilization Ratio (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies has reported Asset Utilization Ratio for 8 years, with the latest figure at 0.19 in Q4 2025.
- For the quarter ending Q4 2025, Asset Utilization Ratio rose 246.72% year-over-year to 0.19; the trailing twelve-month figure through Dec 2025 stood at 0.19 (up 246.72% YoY), and the FY2025 full-year result was 0.16, up 724.72% from the prior year.
- Asset Utilization Ratio for Q4 2025 stood at 0.19, up from 0.16 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 3233.58 in Q2 2024, with the low at 0.01 in Q4 2022.
- Historically, Asset Utilization Ratio has averaged 544.43 across 5 years, with a median of 0.28 in 2025.
- Annual changes were most pronounced in 2023 — Asset Utilization Ratio soared 18160145.53% — and 2024, when it slumped 100.0%.
- CollPlant Biotechnologies' Asset Utilization Ratio stood at 0.3 in 2021, then slumped by 95.35% to 0.01 in 2022, then soared by 18160145.53% to 2517.94 in 2023, then tumbled by 100.0% to 0.05 in 2024, then soared by 246.72% to 0.19 in 2025.
- The last three Asset Utilization Ratio figures came in at 0.19 (Q4 2025), 0.16 (Q3 2025), and 0.28 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 0.55 |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 0.60 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 1,422.00 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.19 |
| Sep 30, 2025 | 0.16 |
| Jun 30, 2025 | 0.28 |
| Mar 31, 2025 | 0.26 |
| Dec 31, 2024 | 0.05 |
| Sep 30, 2024 | 0.05 |
| Jun 30, 2024 | 3,233.58 |
| Mar 31, 2024 | 2,518.46 |
| Dec 31, 2023 | 2,517.94 |
| Sep 30, 2023 | 2,067.49 |
| Jun 30, 2023 | 0.28 |
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.03 |
| Dec 31, 2021 | 0.30 |
| Sep 30, 2021 | 0.40 |
| Jun 30, 2021 | 0.77 |
| Mar 31, 2021 | 3.94 |
| Dec 31, 2020 | 0.64 |